fMRI Analysis of Aging and Awareness in Conditioning

December 4, 2025 updated by: Johns Hopkins University

Functional Magnetic Resonance Imaging (fMRI) Analysis of Aging and Awareness in Conditioning

Cathodal Transcranial direct current stimulation (tDCS) was administered to the right parietal region in order to determine if this stimulation could disrupt awareness of the conditioned stimulus (CS) - unconditioned stimulus (US) relationship in a classical conditioning experiment.

Study Overview

Study Type

Interventional

Enrollment (Estimated)

16

Phase

  • Not Applicable

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

20 years to 30 years (Adult)

Accepts Healthy Volunteers

Yes

Description

Inclusion Criteria:

  • Educational attainment of at least eight years and English as the native language
  • Mini-Mental State Examination (MMSE) score of 26
  • Normal episodic memory (i.e., CERAD word List Recall > 5)
  • Informed consent; 5) age of 20-30

Exclusion Criteria:

  • Disturbed consciousness
  • Other neurological or systemic disorder which can cause dementia or cognitive dysfunction
  • Prior history of a major psychiatric disorder
  • History of definite stroke
  • Focal lesion on MRI exam
  • Use of anxiolytic, antidepressant, neuroleptic, or sedative medication
  • Predominately left-handed
  • Has MRI contraindication such as pacemaker, implanted pumps, shrapnel, etc. (full MRI screening form will be filled out).

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Basic Science
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Single

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Sham Comparator: sham tDCS
tDCS delivered for only 30 sec to replicate tingling sensation and blind subject
transcranial direct current stimulation applied at 2 mA over the right parietal region for 30 sec
Experimental: cathodal tDCS
cathodal tDCS, 2 milliamps (mA), delivered to right parietal region
transcranial direct current stimulation applied at 2 mA over the right parietal region for 20 min

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
CS-US Awareness
Time Frame: recorded immediately after the 20 minutes of tDCS stimulation
To assess CS-US awareness, we used a questionnaire The questionnaire consists of 7 true/false questions about the sequence and co-occurrence of the conditioned stimulus (CS, a 1000 Hz tone) and unconditioned stimulus (US, a 100 ms puff of air to the eye). The score can thus range from 0 to 7. Higher score values indicate better awareness of the sequence and co-occurrence of the CS and US
recorded immediately after the 20 minutes of tDCS stimulation

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Line bisection test of left-hemifield neglect
Time Frame: recorded immediately after primary awareness questionnaire

The subject is given a sheet of paper with a number of horizontal lines on it. The subject is instructed to cut each line in half by drawing a small pencil mark through each line. The test is scored by measuring the percent deviation, which is calculated by the following formula:

Percent deviation=100 x (measured left half - true half)/true half This yields positive numbers for marks placed to the right of center, and negative numbers for marks placed to the left of center. Patients with right hemisphere damage and contralateral neglect show higher positive line bisection scores compared to healthy controls or patients without right hemisphere damage and vice versa.

recorded immediately after primary awareness questionnaire
Eyeblink conditioned responding
Time Frame: recorded during the tDCS administration
Eyeblink conditioning is recorded while the subject watches a silent movie. For conditioning, the conditioned stimulus (CS) is a 1350 ms 1000 Hz tone. This tone co-terminates with a 100 ms left corneal airpuff (5 psi). 30 CS-US presentations are delivered at an average rate of one every 18 sec. Conditioned responses (CRs) are defined as follows: the difference between the maximum and minimum responses in a 500 ms pre-US time window must exceed four times the standard deviation of the mean of the baseline period (250 ms pre-CS presentation). The 500 ms pre-US time window was selected to minimize the inclusion of voluntary and alpha responses as CRs. Performance is expressed as % CRs, that is, the percent of trials in which a CR occurred. Greater numbers indicate greater amounts of learning.
recorded during the tDCS administration

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: John Desmond, Johns Hopkins University

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

November 9, 2010

Primary Completion (Estimated)

December 31, 2026

Study Completion (Estimated)

December 31, 2026

Study Registration Dates

First Submitted

August 30, 2018

First Submitted That Met QC Criteria

August 30, 2018

First Posted (Actual)

August 31, 2018

Study Record Updates

Last Update Posted (Actual)

December 11, 2025

Last Update Submitted That Met QC Criteria

December 4, 2025

Last Verified

December 1, 2025

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Transcranial Direct Current Stimulation

Clinical Trials on sham transcranial direct current stimulation

Subscribe